Brief: G1 Therapeutics Provides Fourth Quarter And Full Year 2022 Financial Results
01/03/2023 11:36
March 1 (Reuters) - G1 Therapeutics Inc GTHX.O :
* G1 THERAPEUTICS PROVIDES FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* EXPECTS TO GENERATE BETWEEN $50 MILLION AND $60 MILLION IN
COSELA NET REVENUE IN 2023
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.73
Source text for Eikon: ID:nGNX4hdZVc
Further company coverage: GTHX.O
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify